Current management of portal vein thrombosis in liver transplantation

Int J Surg. 2020 Oct:82S:122-127. doi: 10.1016/j.ijsu.2020.04.068. Epub 2020 May 5.

Abstract

Nontumoral portal vein thrombosis (PVT) is present at liver transplantation (LT) in 5-26% of cirrhotic patients, and is known to affect post LT outcomes. Up to 31% of patients who are found to have PVT at the time of LT, would have had PVT at the time of initial listing, but others develop PVT during the waiting period. Adequate screening and treatment of the PVT on the waiting list for LT is thus essential so that a portoportal anastomoses can be performed at the time of LT. Early PVT (Yerdel Grade I/II) can be usually managed by thrombectomy, whereas Grade III PVT may require a jump graft from the superior mesenteric vein to the graft PV. Complete portomesenteric thrombosis is a huge challenge, and sometimes a cause for denying a LT in these patients, with multivisceral transplant being the only alternative. The presence of spontaneous, or previously surgically created portosytemic shunts like the leinorenal shunt, may serve as a good inflow option (renoportal anastomosis) in these patients to establish a physiological reconstruction. Although challenging, good outcomes are possible in patients with complex PVT if the appropriate surgical technique is chosen to ensure portal inflow and resolution of PHT post LT.

Keywords: Intraoperative management; Outcomes; PVT grade; Physiological reconstruction; Portal vein thrombosis.

Publication types

  • Review

MeSH terms

  • Female
  • Humans
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / surgery
  • Liver Transplantation
  • Male
  • Mesenteric Veins / surgery*
  • Middle Aged
  • Portal Vein / transplantation*
  • Thrombectomy / methods*
  • Vascular Surgical Procedures / methods*
  • Venous Thrombosis / etiology
  • Venous Thrombosis / surgery*
  • Waiting Lists